MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2007 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
304 M |
Marktkapitalisierung |
$ 4.35 B |
EBITDA (LTM) |
$ 46.2 M |
P/E (LTM) |
-130.0 |
P/S (LTM) |
7.37 |
EPS (LTM) |
-0.11 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Adagene
ADAG
|
$ 1.65 | 7.91 % | $ 92.9 M | Nasdaq Global Market |  China |
 |
AstraZeneca PLC
AZN
|
$ 93.52 | -1.2 % | $ 96.9 B | Nasdaq Global Select Market |  Britain |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.52 | -16.3 % | $ 388 M | Nasdaq Global Select Market | Britain |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.59 | 1.99 % | $ 8.64 B | Nasdaq Capital Market |  Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Biogen
BIIB
|
$ 184.48 | -1.67 % | $ 26.9 B | Nasdaq Global Select Market,SPB | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 102.17 | 2.32 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 4.25 | 1.67 % | $ 9.25 B | NYSE American |  Israel |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Ascendis Pharma A/S
ASND
|
$ 207.49 | 2.22 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Catalyst Biosciences
CBIO
|
$ 10.84 | 0.46 % | $ 714 M | Nasdaq Capital Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 37.35 | -0.4 % | $ 3.86 B | Nasdaq Capital Market,SPB | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 23.18 | 2.02 % | $ 2.75 B | Nasdaq Capital Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 25.59 | -6.54 % | $ 1.65 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 4.22 | -4.2 % | $ 116 M | Nasdaq Global Market | France |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 29.43 | 6.09 % | $ 1.43 B | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Burford Capital Limited
BUR
|
$ 9.66 | 2.28 % | $ 1.53 B | NYSE | Britain |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 66.05 | 2.3 % | $ 8.83 B | Nasdaq Global Select Market,SPB | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 55.11 | 3.49 % | $ 4.45 B | Nasdaq Global Select Market | USA |
 |
Abeona Therapeutics
ABEO
|
$ 5.14 | -1.06 % | $ 110 M | Nasdaq Capital Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 55.17 | 2.47 % | $ 4.65 B | Nasdaq Global Market,SPB |  Schweiz |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Axon Enterprise
AXON
|
$ 632.29 | 0.09 % | $ 47.9 B | Nasdaq Global Select Market,SPB | USA |
 |
ADiTx Therapeutics
ADTX
|
$ 0.81 | 1.96 % | $ 10.7 K | Nasdaq Capital Market | USA |
 |
Aytu BioScience
AYTU
|
$ 2.7 | 2.27 % | $ 17 M | Nasdaq Capital Market | USA |